Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.31 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.31 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.31 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.31 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.31 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14424539 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TDP1CA2GRIK1GRIA2 | |
| SCHEMBL5163841 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TDP1CA2GRIK1GRIA2 | |
| SCHEMBL26977118 | 0.77 | ALDH1A1 (0.30) | ALDH1A1TDP1 | |
| SCHEMBL19946353 | 0.69 | — | — | |
| SCHEMBL3466462 | 0.69 | — | — | |
| SCHEMBL26977352 | 0.68 | ALDH1A1 (0.33) | ALDH1A1TDP1CA2 | |
| SCHEMBL5163858 | 0.65 | ALDH1A1 (0.39) | ALDH1A1TDP1CA2 | |
| SCHEMBL26977102 | 0.65 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL28571483 | 0.63 | ALDH1A1 (0.40) | ALDH1A1TDP1CA2 | |
| SCHEMBL12617100 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7259135-B2 | Use of hexenal derivatives as perfumes | KAO CORPORATION (JP) | 2007-08-21 | — | — | US | claimed |
| US-7259135-B2 | Use of hexenal derivatives as perfumes | KAO CORPORATION (JP) | 2007-08-21 | — | — | US | disclosed |
| EP-1476527-B1 | USE OF HEXENAL DERIVATIVES AS PERFUMES | KAO CORP (JP) | 2007-04-11 | — | — | EP | disclosed |
| US-20050130875-A1 | Use of hexenal derivates as perfumes | KAO CORPORATION (JP) | 2005-06-16 | — | — | US | disclosed |
| EP-1476527-A1 | USE OF HEXENAL DERIVATIVES AS PERFUMES | Kao Corporation (JP) | 2004-11-17 | — | — | EP | disclosed |
| WO-2003070864-A1 | USE OF HEXENAL DERIVATIVES AS PERFUMES | KAO CORPORATION (JP) | 2003-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050130875-A1 | Use of hexenal derivates as perfumes | ADH1C, ADH5, ZDHHC2 | ALDH1A1 113/4885TDP1 2815/4885CA2 2105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.